Therapeutic agent for pulmonary emphysema
US9533070B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Aug 10, 2011 |
| Grant date | Jan 3, 2017 |
| Priority date | — |
| Expiry date | Aug 10, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M2210/1039
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention has as its object the provision of a medicine capable of reducing a volume of emphysema-suffering pulmonary alveoli or alveolar sacs by means of a respiratory region volume inhibitor containing a coating film formation as a main component and capable of forming a coating film in a respiratory region, characterized by being used in such a way that the coating film-forming component is administered to an emphysema-suffering pulmonary alveolar parenchyma in a human-respiratory region in an amount of 0.004 to 200 g/application, preferably 0.07 to 20 g/application and more preferably 0.5 to 5 g/application on each occasion.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.